Skip to main content

Posts

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP)

Published on: 2026-09-16T04:00:00Z Conditions : Hypertension; Cardiovascular Diseases (CVD); Vascular Diseases Interventions : Device: Automated Office Blood Pressure (AOBP) Standardized Measurement Protocol Sponsors : Menzies Institute for Medical Research; National Health and Medical Research Council, Australia; Hypertension Australia; Australian Cardiovascular Alliance; Pharmaceutical Society of Australia; Ochre Health; Uscom Limited; JA Davey; A&D Australasia; Servier Laboratories (Australia) Pty Ltd; National Heart Foundation, Australia Not yet recruiting https://ift.tt/1x3AW4B

Latest Posts

New diabetes clinical trial: NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

New diabetes clinical trial: Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination

New diabetes clinical trial: Dancing as an Alternative to the Traditional Exercising in Older Adults With Cardiac Diseases

New diabetes clinical trial: Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App

New diabetes clinical trial: Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

New diabetes clinical trial: Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A PragmaTIC Cluster Randomized Controlled Trial (HOLISTIC)

New diabetes clinical trial: Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome

New diabetes clinical trial: Integrated Diabetes and Oral Health Care in Oman

New diabetes clinical trial: Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk

New diabetes clinical trial: Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity